#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Langerhans cell sarcoma Chronic graft versus host disease in skin Glycogen storage disease type I Allogenic stem cell transplantation Cerebral amyloid angiopathy Usher's syndrome Hodgkin's disease recurrent Haemolytic uraemic syndrome Still's disease Intracranial germ cell tumour Hepatitis D Craniocerebral injury Nephrotic syndrome Warm autoimmune haemolytic anaemia Metachromatic leukodystrophy More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Treatment Basal cell naevus syndrome Short-bowel syndrome – Trials in Disease Cerebral arteriovenous malformation haemorrhagic – Life with Disease Von Willebrand’s disease – Treatment Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease Soft tissue sarcoma – Treatment Hairy cell leukaemia recurrent – Trials in Disease Netherton’s syndrome – Basic Information Noonan syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mifepristone Paraffin White Soft Letrozole Aticaprant Fosamprenavir Calcium Folinic Acid Jnj-81241459 IBANDRONIC ACID Ethambutol Hydrochloride Guselkumab SODIUM TETRACHLOROPALLADATE Alanyl Glutamine Cyclophosphamide Monohydrate Flortaucipir (18F) Levocarnitine Repagermanium Transpocart19 Mk-1088 Clazakizumab Rbd4059 More therapies…

    Learn about Your Condition

    Rett syndrome Naevoid melanoma Drug use disorder Sepsis Injection site pain Acute leukaemia Gastrooesophageal cancer Malignant melanoma stage III Oral lichen planus Menopause B-cell type acute leukaemia Endocarditis Erdheim-Chester disease Dementia Alzheimer's type Choroidal dystrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hippokrateslaan 10, Batiment 54, Woluwe-Saint-Lambert, 1200, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Colesevelam Hydrochloride for Patients with Idiopathic Bile Acid Diarrhea (BAD)

    Recruiting

    2 1
    Investigated Drugs:
    • COLESEVELAM HYDROCHLORIDE
    Belgium Denmark Italy Romania Spain

  • Study on the Safety and Effectiveness of Capivasertib and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer After Hormone Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer female
    • Hormone receptor positive breast cancer
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Capivasertib
    Belgium Germany Portugal

  • Study of RLY-2608 for Adults and Children with PIK3CA-Related Overgrowth and Malformations

    Recruiting

    2 1 1
    Investigated Drugs:
    • RLY-2608
    Belgium France Germany Ireland Italy Norway +1

  • Study of Relacorilant, Nab-Paclitaxel, and Bevacizumab for Patients with Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Peritoneal neoplasm
    • Endometrial cancer
    Investigated Drugs:
    • Relacorilant
    • Bevacizumab
    • Paclitaxel Albumin-Bound
    Belgium France Germany Italy Poland Spain

  • Study of clopidogrel and acetylsalicylic acid (aspirin) for prevention of cardiovascular events in patients who survived intracerebral hemorrhage stroke

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cerebral haemorrhage
    Investigated Drugs:
    • Clopidogrel
    • Acetylsalicylic Acid
    Belgium The Netherlands

  • Study Comparing Zilovertamab Vedotin with Drug Combination for Untreated Patients with Diffuse Large B-Cell Lymphoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Polatuzumab Vedotin
    • Zilovertamab Vedotin
    • Cyclophosphamide
    Belgium Germany Ireland Italy Poland

  • Study of elranatamab and lenalidomide combination versus standard chemotherapy and transplant in newly diagnosed multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bortezomib
    • Daratumumab
    • Dexamethasone
    Belgium France

  • Study on the Safety and Effectiveness of GSK5733584 with Dostarlimab and Carboplatin for Patients with Advanced Gynecological Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • GSK5733584
    • Bevacizumab
    • Dostarlimab
    Belgium Denmark Finland France Germany Greece +6

  • Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • BNT327
    • Pemetrexed Disodium
    • Carboplatin
    Belgium Bulgaria France Germany Hungary Italy +3

  • Study of Trastuzumab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    • Capecitabine
    • Cisplatin
    Austria Belgium Czechia France Germany Italy +6
Previous Page
1 … 10 11 12 13 14 … 67
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!